ResMed Director Awarded RSU Grant for 1,073 Shares
RESMED INC
Subscribe to track RMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
ResMed Director Awarded RSU Grant
Company: RESMED INC (RMD) Form: 4 | Filed: 2025-11-24 Significance: Low
Insider: Burt Carol Title: null | Relationship: Director
Transaction: • Type: Grant • Shares: 1,073 • Price: $0.00 • Value: $0 • Owned After: 18,816 (Direct & Indirect)
Key Insight: This is a routine Restricted Stock Unit (RSU) grant for a director, a common form of non-cash compensation. The transaction has a negligible impact on the market due to its small size.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: RESMED INC (RMD)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director received a routine grant of 1,073 Restricted Stock Units (RSUs) as part of their compensation, with no immediate market impact.
- Market Impact: Neutral. This is a standard equity compensation grant, not an open-market transaction, and is immaterial in size.
Company Information
| Field | Value |
|---|---|
| Company | RESMED INC |
| Ticker Symbol | RMD |
| CIK | 0000943819 |
| Industry | Surgical & Medical Instruments & Apparatus |
Insider Information
| Field | Value |
|---|---|
| Name | Burt Carol |
| CIK | 0001493926 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-20 |
| Transaction Code | A (Grant) |
| Security Type | ResMed Common Stock |
| Shares Involved | 1,073 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 18,816 (2,156 Direct, 16,660 Indirect) |
| Ownership Type | Direct (for this transaction) |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.0% |
| Shares Transacted | 1,073 |
| % of Shares Outstanding | 0.00073% |
| Post-Transaction Ownership | 18,816 shares (0.0128% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: With a market capitalization of $35.68 billion, this $0 value grant is financially immaterial.
- Ownership Concentration: The director's total holding of 18,816 shares represents a very small fraction (0.0128%) of the total shares outstanding, indicating low ownership concentration from this insider.
- Dilution Impact: The grant of 1,073 shares represents a negligible potential dilution of 0.00073% to existing shareholders.
- Transaction Significance: The transaction is classified as low significance as it is a non-market award with zero cash value at grant and represents an extremely small percentage of the company's outstanding shares.
Additional Context
Transaction Notes
- Special Circumstances: The filing footnote indicates these are Restricted Stock Units (RSUs) that vest in full on the earlier of November 11, 2026, or the annual stockholders' meeting in the year following the grant. This is a standard equity compensation practice to align director interests with shareholders over the long term.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.